SLIT ABS: Study on Patients With Autoimmune Podocytopathy

Recruiting N/A Interventional Study
Nephrotic Syndrome With Edema (Diagnosis) Minimal Change Nephrotic Syndrome Focal Segmental Glomerulosclerosis (FSGS) Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
0 – 99
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
50 (estimated)
Sponsor
Meyer Children's Hospital IRCCS · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Nephrotic syndrome is a kidney condition that mainly affects children and is characterized by high levels of protein in the urine, low levels of protein in the blood, and swelling. While many children respond well to steroid treatment, a large proportion experience relapses or become dependent on therapy. In some cases, the disease does not respond to standard treatments and may progress to chroni…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Pediatric and adult patients with a diagnosis of podocytopathy * Patients with nephrotic syndrome and/or histological diagnosis of minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), collapsing glomerulopathy (CG), or diffuse mesangial sclerosis (DMS) * Bo…
Contacts

Paola Romagnani, MD, PhD

+39 0555662563

paola.romagnani@meyer.it

CONTACT